Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the United States by 2030, according to the National Institutes of Health (NIH). The International ...

In a proof of concept that may reshape the treatment landscape for insulin-dependent diabetes, scientists have demonstrated that human stomach cells can be reprogrammed to secrete insulin—potentially ...

Scientists have created a new antibody treatment that helps the immune system recognize and attack pancreatic cancer. Pancreatic cancer cells use a sugary "disguise" to trick the immune system into ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and is estimated to affect 9.5 million people worldwide. A potential new ...

Experimental, drug-free, MRI-guided cancer treatment may one day offer a way of targeting and destroying pancreatic tumors without surgery or chemotherapy. (Nanowerk News) A new study has found for ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in metastatic pancreatic cancer. Tumor-treating fields (TTFields) improve overall ...

Pancreatic cancer is mostly pancreatic ductal adenocarcinoma, with late-stage detection due to non-specific symptoms like jaundice and abdominal pain. Diagnosis involves imaging tests, biopsies, and ...

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. With an overall survival rate of around 13%, it’s also one of the deadliest cancers. One reason for this is that ...

A new study from the University of British Columbia has uncovered a direct link between high insulin levels and pancreatic cancer. This research helps explain why people with obesity or Type 2 ...